Page last updated: 2024-08-25

rosiglitazone and 3,4-dihydroxyphenyllactic acid

rosiglitazone has been researched along with 3,4-dihydroxyphenyllactic acid in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dong, P; Fan, G; Fordjour, PA; Gao, H; Gong, B; Li, L; Zhu, Y	1

Other Studies

1 other study(ies) available for rosiglitazone and 3,4-dihydroxyphenyllactic acid

Article	Year
Danshensu Promotes Cholesterol Efflux in RAW264.7 Macrophages. Lipids, 2016, Volume: 51, Issue:9 Topics: Animals; ATP Binding Cassette Transporter 1; ATP Binding Cassette Transporter, Subfamily G, Member 1; CD36 Antigens; Cholesterol; Foam Cells; Gene Expression Regulation; Genetic Markers; Lactates; Lipoproteins, LDL; Macrophages; Mice; PPAR gamma; RAW 264.7 Cells; Rosiglitazone; Simvastatin; Thiazolidinediones	2016

Article

Year

Danshensu Promotes Cholesterol Efflux in RAW264.7 Macrophages.

Lipids, 2016, Volume: 51, Issue:9

Topics: Animals; ATP Binding Cassette Transporter 1; ATP Binding Cassette Transporter, Subfamily G, Member 1; CD36 Antigens; Cholesterol; Foam Cells; Gene Expression Regulation; Genetic Markers; Lactates; Lipoproteins, LDL; Macrophages; Mice; PPAR gamma; RAW 264.7 Cells; Rosiglitazone; Simvastatin; Thiazolidinediones

2016